HOME >> MEDICINE >> NEWS
GroPep licenses technology to TGR BioSciences

GroPep announced today it has licensed its Whey Growth Factor Extract (WGFE) technology to Australian biotechnology company, TGR BioSciences (TGR).

TGR has raised $3 million to fund further clinical development of WGFE as a treatment for oral mucositis, a debilitating side effect of cancer treatments.

GroPep will receive royalties of more than 10% on TGR's commercialisation of the technology.

Biopharmaceutical company GroPep Limited (ASX: GRO) today announced that it has licensed certain Whey Growth Factor Extract (WGFE) technology rights to TGR BioSciences Pty Ltd (TGR). This arrangement will also allow TGR to raise additional funds to finance further development of the technology.

Under two separate agreements, venture capitalist Nanyang Innovation Fund managed by Nanyang Ventures (Nanyang) will invest up to $3 million, TGR will start a clinical trial of WGFE for oral mucositis and GroPep will license the WGFE technology to TGR.

GroPep will receive royalties of more than 10% from TGR on commercialisation of the technology and TGR has taken over responsibility for five patent families developed by GroPep and the related costs. GroPep's shareholding in TGR is reduced from 20% to 12%.

Among the rights licensed to TGR is GroPep's oral mucositis product technology. Oral mucositis is an extremely painful side effect afflicting chemotherapy patients. GroPep and collaborators have previously generated significant preclinical and clinical data, including a successful Phase 1b trial conducted at the Peter MacCallum Cancer Centre in Melbourne, indicating the safety and potential for WGFE to treat this condition. TGR has committed to initiate further clinical development in the oral mucositis setting within the next year.

Mr Gregory Moss-Smith, Vice President of Commercial Operations at GroPep, said "Licensing the technology to TGR, combined with the capital injection from Nanyang, is an effective means of advancing
'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. GroPep to pursue promising asthma drug following preclinical study results
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Doctors working overseas face having licenses removed
7. UW licenses innovated cardiovascular software to VPDiagnostics
8. The Wistar Institute licenses rubella vaccine seed stock to Microgen of Russia
9. MCW Research Foundation licenses invention for stroke treatment
10. Wireless technology shows promise in diagnosing pediatric intestinal disease
11. Speeding up CT scans with cellphone technology, ultrasound warning signal for breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: